Research Article
Ocular Manifestations of Biopsy-Proven Pulmonary Sarcoidosis in Korea
Table 2
Clinical features by type of biopsy for confirmation of sarcoidosis.
| | Transbronchial () | Excisional (lung) () | Extrapulmonary () | value |
| | Mean age | 53.8 ± 13.9 | 53.5 ± 15.5 | 57.9 ± 16.2 | 0.96 | | Female/male ratio | 31/7 | 5/3 | 9/0 | 0.14 | | Ocular involvement | 25 (65.8%) | 5 (62.5%) | 9 (100%) | 0.11 | | BHLa in radiography | 35 (92.1%) | 7 (87.5%) | 7 (77.8%) | 0.46 | | Increased ACEb | 27 (68.4%) | 5 (62.5%) | 6 (66.7%) | 0.95 | | ACEb level | 73.8 ± 40.0 | 65.9 ± 36.4 | 72.2 ± 43.8 | 0.87 | | Visual acuity at last visit | 0.82 ± 0.23 | 0.92 ± 0.13 | 0.83 ± 0.25 | 0.75 | | Systemic treatment | 21 (55.3%) | 4 (50.0%) | 8 (88.9%) | 0.15 | | Immunosuppression | 9 (23.7%) | 1 (12.5%) | 6 (66.7%) | 0.29 |
|
|
aBilateral hilar lymphadenopathy; bangiotensin-converting enzyme.
|
